Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7928400 | 0.85 | CA1 (0.40) | CA1CA2CA9NPC1RAB9A | |
| SCHEMBL28596361 | 0.84 | TSHR (0.43) | CA1CA2CA9SMN1; SMN2CYP2A6 | |
| SCHEMBL19974058 | 0.84 | SIGMAR1 (0.41) | CA1CA2CA9NPC1RAB9A | |
| SCHEMBL8290989 | 0.82 | TAAR1 (0.40) | SMN1; SMN2CYP2A6HTR2ATAAR1LOXL2 | |
| SCHEMBL19974320 | 0.82 | CA1 (0.43) | CA1CA2CA9NPC1RAB9A | |
| SCHEMBL8456049 | 0.81 | ALDH1A1 (0.42) | CA1CA2CA9SMN1; SMN2CYP2A6 | |
| SCHEMBL1101315 | 0.81 | CA1 (0.48) | CA1CA2CA9NPC1RAB9A | |
| SCHEMBL8397899 | 0.78 | ALDH1A1 (0.39) | CA1CA2CA9SMN1; SMN2CYP2A6 | |
| SCHEMBL8835472 | 0.78 | CMA1 (0.42) | CA1CA2CA9NPC1RAB9A | |
| SCHEMBL2817046 | 0.78 | TDP1 (0.47) | CA1CA2CA9NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3500544-A1 | OIL-SOLUBLE PLANT MICRONUTRIENTS | Huntsman Petrochemical LLC (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20190161418-A1 | OIL-SOLUBLE PLANT MICRONUTRIENTS | INDORAMA VENTURES OXIDES LLC | 2019-05-30 | — | — | US | disclosed |
| WO-2018034864-A1 | OIL-SOLUBLE PLANT MICRONUTRIENTS | HUNTSMAN PETROCHEMICAL LLC (US) | 2018-02-22 | — | — | WO | disclosed |
| US-20060079610-A1 | Salt-like reaction products of hals derivatives and phosphor-cntaining organic acids for the stabilisation of polymeric materials | CLARIANT FINANCE (BVI) LIMITED (VG) | 2006-04-13 | — | — | US | disclosed |
| EP-1597311-A1 | SALT-LIKE REACTION PRODUCTS OF HALS DERIVATIVES AND PHOSPHOR-CONTAINING ORGANIC ACIDS FOR THE STABILISATION OF POLYMERIC MATERIALS | Clariant Finance (BVI) Limited (VG) | 2005-11-23 | — | — | EP | disclosed |
| WO-2004074365-A1 | SALT-LIKE REACTION PRODUCTS OF HALS DERIVATIVES AND PHOSPHOR-CONTAINING ORGANIC ACIDS FOR THE STABILISATION OF POLYMERIC MATERIALS | CLARIANT INTERNATIONAL LTD (CH) | 2004-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190161418-A1 | OIL-SOLUBLE PLANT MICRONUTRIENTS | PNPO, SLC19A1, SLC6A12 | CA1 2102/4885CA2 1121/4885CA9 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.